drugset / Trial / NCT05750446
Effect of Riocigaut on Migraine Attack Induction in People With Migraine
RandomizedCrossoverQuadruple-blindOther
Summary
This double-blind, randomized, placebo-controlled cross-over clinical trial aims to investigate the effects of riocigaut on migraine inducing properties in people with migraine.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riociguat | Other / unclassified | — | Oral |